Related Experiment Video

Updated: Oct 26, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.0K

Is it time to vaccinate children?

Clare Wilson

    New Scientist (1971)
    |July 26, 2021
    PubMed

    Insights

    The UK faces a decision on pediatric COVID-19 vaccination amid rising cases and eased restrictions. Clare Wilson examines the advantages and disadvantages of vaccinating children against the virus.

    Area of Science:

    • Public Health
    • Epidemiology
    • Pediatric Medicine

    Background:

    • COVID-19 cases are increasing in the UK.
    • Public health restrictions are being relaxed across the country.
    • The question of vaccinating children against COVID-19 is a growing concern.

    Purpose of the Study:

    • To evaluate the benefits of COVID-19 vaccination for children.
    • To assess the risks and potential drawbacks of pediatric COVID-19 vaccination.
    • To inform the UK's decision-making process regarding child vaccination programs.

    Main Methods:

    • Review of current scientific literature on pediatric COVID-19.
    • Analysis of epidemiological data on child transmission and severity.
    • Examination of vaccine safety and efficacy data in pediatric populations.

    Main Results:

    • Data suggests varying levels of COVID-19 impact on children.
    • Vaccine efficacy and safety profiles in children are under ongoing investigation.
    • Potential benefits include reduced transmission and disease severity.

    Conclusions:

    • The decision requires careful consideration of scientific evidence and public health goals.
    • Balancing the pros and cons is crucial for protecting child health and well-being.
    • Further research may be needed to fully understand long-term effects.

    More Related Videos

    Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children06:22

    Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

    Published on: February 10, 2023

    1.1K
    Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines05:39

    Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

    Published on: October 30, 2018

    12.3K

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    47.3K
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    57
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    47
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    57
    Dosage Interval and Administration Route: Determination Methods01:19

    Dosage Interval and Administration Route: Determination Methods

    A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
    52
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    45